Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
January 29, 2025, ACS Practice Management
Lessons Learned from a Medical Malpractice Lawsuit: Aortic Surgery in a Patient with Significant Underlying Coronary Disease
David Han, MD, FACS, and Jacqueline Ross, RN, PhD, Coding Director, The Doctors Company, part of TDC Group, discuss the complications and critical decision-making errors in a case of aortic surgery on a patient with severe coronary disease. The article emphasizes the importance of thorough preoperative evaluation and considering all surgical options to manage complications effectively.
Supporting Pediatric Cancer Research
The employees of TDC Group—The Doctors Company, Healthcare Risk Advisors, TDC Specialty Underwriters, and Medical Advantage—consistently demonstrate their generosity to the causes they care most about. Many seek matching funds from the TDC Group Employee Gift Matching Program to double their donations to causes they care about.
July 01, 2025, Physicians Practice
How to Counter Medical Misinformation and Support Engaged Patients
In a recent survey of physicians by The Doctors Company, 64 percent of physicians named misinformation on social media one of the most challenging aspects of practicing medicine. Correcting misinformation during an office visit requires time, effort, and building trust in the physician-patient relationship.
Exclusively Endorsed by ASPS
The American Society of Plastic Surgeons exclusively endorses The Doctors Company. ASPS members receive unique benefits, including exclusive program discounts and credits.
2024 AM Best Ratings
September 30, 2024: AM Best has affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and its long-term issuer credit rating (ICR) of "a+”. The outlook of these ratings is stable.
Education for Advanced Practice Clinicians
We are proud to be the industry leader in providing essential patient safety resources and unparalleled options for contact hours and continuing education for advanced practice clinicians.
February 24, 2024, Risk Management and Healthcare Policy
Analysis of Closed Claims Among All Medical Specialties: Importance of Communication and Other Non-Clinical Contributing Factors
Evaluation of contributing factors associated with medical malpractice claims provides important information to optimize the patient–provider relationship. This review of closed claims from The Doctors Company highlights common factors contributing to lawsuits and strategies to avoid them, with a particular focus on communication.
Mar 20, 2019
Study of Malpractice Claims Involving Children
The Doctors Company analyzed 1,215 claims filed on behalf of pediatric patients that closed from 2008 through 2017. The study is based on the claims filed against physicians in 52 specialties and subspecialties and includes an overview of the most common types of claims, expert insights into the specific elements that led to patient injury, and risk mitigation strategies.
Mar 04, 2024
Spotlight on Foundation Grants: OR Crisis Checklists
The Doctors Company Foundation highlights a project by Ariadne Labs to update and expand its successful operating room checklist compendium.
From
The Doctor’s Advocate
